About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
News
All categories
Portfolio
Portfolio
Gemabank
Genetico
Betuvax
Nextgen
Biotechnology Developments
Reprobank
Vitacel
27.03.2023
News
ACRA confirmed the BB+(RU) credit rating of HSCI
24.03.2023
News
RBT raises funds on the Rounds platform
21.03.2023
News
Gemabank changes the biomaterials storage rate
20.03.2023
News
Reprobank celebrates its 10th anniversary
15.03.2023
News
National Technology Initiative to develop gene therapy and genetic testing market
07.03.2023
News
Candidates for the Board of Directors and Internal Audit Board HSCI OJSC have been selected
10.02.2023
News
An HSCI company became a resident of the Lomonosov Cluster
1
2
3
4
5
6
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
